Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis B Patients With HBeAg-positive”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01220596
What this trial is testing

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hanyang University 228
Post-approval studies (Phase 4)WithdrawnNCT01727271
What this trial is testing

Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)

Who this might be right for
Hepatitis B
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT03903796
What this trial is testing

Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic HBV Infection
Jiangsu Hansoh Pharmaceutical Co., Ltd. 963
Post-approval studies (Phase 4)Study completedNCT02598063
What this trial is testing

Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 255
Early research (Phase 1)Study completedNCT02401737
What this trial is testing

Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients

Who this might be right for
Chronic Hepatitis B
Novira Therapeutics, Inc. 58
Post-approval studies (Phase 4)Study completedNCT00436163
What this trial is testing

Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 39
Not applicableStudy completedNCT01011738
What this trial is testing

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 1,842
Post-approval studies (Phase 4)Study completedNCT00927082
What this trial is testing

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 383
Testing effectiveness (Phase 2)Study completedNCT03576066
What this trial is testing

A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis B
Assembly Biosciences 73
Post-approval studies (Phase 4)UnknownNCT02368288
What this trial is testing

Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 200
Post-approval studies (Phase 4)Study completedNCT02604823
What this trial is testing

Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 307
Post-approval studies (Phase 4)UnknownNCT04565262
What this trial is testing

Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years

Who this might be right for
HBeAg Positive Chronic Hepatitis B
Beijing 302 Hospital 200
Post-approval studies (Phase 4)Study completedNCT00614471
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 219
Post-approval studies (Phase 4)Study completedNCT00962533
What this trial is testing

EFFicacy Optimization Research of Telbivudine Therapy

Who this might be right for
Hepatitis B, Chronic
Nanfang Hospital, Southern Medical University 606
Large-scale testing (Phase 3)UnknownNCT01769833
What this trial is testing

HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance

Who this might be right for
Chronic Hepatitis B
Pusan National University Hospital 144
Post-approval studies (Phase 4)UnknownNCT02474316
What this trial is testing

Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients

Who this might be right for
Chronic Hepatitis B
Ruijin Hospital 366
Post-approval studies (Phase 4)Study completedNCT01913431
What this trial is testing

Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B

Who this might be right for
HBeAg-Positive Chronic Hepatitis B
Dong-A ST Co., Ltd. 118
Early research (Phase 1)Looking for participantsNCT06885710
What this trial is testing

HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Changhai Hospital 19
Not applicableStudy completedNCT01732354
What this trial is testing

Study for Consolidation Period of Chronic Hepatitis B

Who this might be right for
Hepatitis B
Tainan Municipal Hospital 137
Post-approval studies (Phase 4)Study completedNCT00435825
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB).

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 551
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation